The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose-Reference-Cited by-同舟云学术

The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose

Author:

Luque-Paz David¹²,Sesques Pierre³,Wallet Florent⁴,Bachy Emmanuel³,Ader Florence²⁵

Affiliation:

1. Service de Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, CHU Rennes, Rennes, France

2. Département des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France

3. Service d’Hématologie Clinique, Hospices Civils de Lyon, Pierre-Bénite, France

4. Service d’Anesthésie, Médecine Intensive, Réanimation, Hospices Civils de Lyon, Pierre-Bénite, France

5. CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, Université Claude Bernard Lyon 1, Lyon, France

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

Reference82 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献